In Iceland, the current research & development by business enterprise, pharmaceutical industry in constant ppp $ is 0.09 million, which reflects a decrease of 0.05 million (-35.1%) compared to 2021.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Iceland
No matching regions
Similar regions to Iceland
Business R&D pharmaceutical in constant PPP $
More indicators for Iceland
Government R&D in security as % of government support
0%
0%
(2021)
Higher-education-finacing R&D financed by general university in local currency
61,479.53M
+8,624.32M
(2022)
R&D financed by rest of the world in local currency
178,428.87M
-17,726.91M
(2022)
Government R&D financed by rest of the world in local currency
2,060.04M
+1,392.46M
(2022)
Business R&D financed by rest of the world in local currency
154,963.49M
-25,404.12M
(2022)
Non-profit R&D growth rate
-3.2%
-2.63%
(2009)
Iceland Business R&D pharmaceutical in constant PPP $ between 2013 and 2022
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2022 | 0.09M | -0.05M |
| 2021 | 0.13M | -0.22M |
| 2020 | 0.35M | +0.05M |
| 2019 | 0.30M | -1.03M |
| 2018 | 1.33M | +0.31M |
| 2017 | 1.02M | -0.32M |
| 2016 | 1.34M | +0.35M |
| 2015 | 0.99M | +0.74M |
| 2014 | 0.25M | -0.13M |
| 2013 | 0.38M |